South Korea’s SK Bioscience to buy control of Germany’s IDT Biologika for $244 mln
SK Bioscience will acquire a 60% stake in German pharmaceutical contract manufacturing firm IDT Biologika GmbH from Klocke Gruppe in a deal worth …Read More
The Heartbeat of World events
SK Bioscience will acquire a 60% stake in German pharmaceutical contract manufacturing firm IDT Biologika GmbH from Klocke Gruppe in a deal worth …Read More